Futian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Futian Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Edward Lank
Cheriton School of Computer Science, University of Waterloo, Waterloo, Ontario, Canada
1 shared publication - Jun Zhao
Department of Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication - Keiko Katsuragawa
National Research Council Canada, Waterloo, Ontario, Canada and Cheriton School of Computer Science, University of Waterloo, Waterloo, Ontario, Canada
1 shared publication - Li Jin
Fudan University
1 shared publication - Liang Chen
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
1 shared publication - Likun Yang
Fang Zongxi Center for Marine EvoDevo, MoE Key Laboratory of Marine Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China
1 shared publication
Latest Publications
- Open Access
- 14 November 2022
- Published by Association for Computing Machinery (ACM) in Proceedings of the ACM on Human-Computer Interaction
- Vol. 6 (ISS) , 103-117
Conductor: Intersection-Based Bimanual Pointing in Augmented and Virtual Reality
Pointing is an elementary interaction in virtual and augmented reality environments, and, to effectively support selection, techniques must deal with the challenges of occlusion and depth specification. Most of the previous techniques require two explicit steps to handle occlusion. In this paper, we propose Conductor, an intuitive, plane-ray, intersection-based, 3D pointing technique where users leverage bimanual input to control a ray and intersecting plane. Conductor allows users to use the non-dominant hand to adjust the cursor distance on the ray while pointing with the dominant hand. We evaluate Conductor against Raycursor, a state-of-the-art VR pointing technique, and show that Conductor outperforms Raycursor for selection tasks. Given our results, we argue that bimanual selection techniques merit additional exploration to support object selection and placement within virtual environments.
- 14 November 2022
- Published by Association for Computing Machinery (ACM) in Proceedings of the ACM on Human-Computer Interaction
- Vol. 6 (ISS) , 103-117
Open AccessConductor: Intersection-Based Bimanual Pointing in Augmented and Virtual Reality
Pointing is an elementary interaction in virtual and augmented reality environments, and, to effectively support selection, techniques must deal with the challenges of occlusion and depth specification. Most of the previous techniques require two explicit steps to handle occlusion. In this paper, we propose Conductor, an intuitive, plane-ray, intersection-based, 3D pointing technique where users leverage bimanual input to control a ray and intersecting plane. Conductor allows users to use the non-dominant hand to adjust the cursor distance on the ray while pointing with the dominant hand. We evaluate Conductor against Raycursor, a state-of-the-art VR pointing technique, and show that Conductor outperforms Raycursor for selection tasks. Given our results, we argue that bimanual selection techniques merit additional exploration to support object selection and placement within virtual environments.
- Open Access
- 17 January 2020
- Published by Wiley in The FASEB Journal
- Vol. 34 (3) , 4072-4084
miR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma
Bladder cancer is one of the most common urogenital malignancies. However, its pathogenesis, especially molecular mechanisms remain elusive. Thus, understanding the molecular mechanisms underlying bladder cancer is important for the discovery of novel therapeutic paradigms for these diseases. In current study, we found that micro‐RNA (miR)‐190b is highly expressed in bladder cancer tissues and cells. Overexpression of miR‐190b enhanced the proliferation, growth, migration and invasion capabilities, and angiogenesis of bladder cancer cells, whereas downregulation of miR‐190b reversed these effects. Target prediction and dual luciferase reporter assays identified NLR family CARD domain containing 3 (NLRC3) as a potential target of miR‐190b. Pathway analysis indicated that miR‐190b promotes bladder cancer progression via the Wnt/β‐catenin and mTOR signaling pathways. Taken together, our findings imply that miR‐190b acts as a critical regulator for bladder cancer development by repressing NLRC3 and partly through the Wnt/β‐catenin and mTOR pathways. Our study suggests that miR‐190b may be served as a potential therapeutic target for bladder cancer treatment.
- 17 January 2020
- Published by Wiley in The FASEB Journal
- Vol. 34 (3) , 4072-4084
Open AccessmiR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma
Bladder cancer is one of the most common urogenital malignancies. However, its pathogenesis, especially molecular mechanisms remain elusive. Thus, understanding the molecular mechanisms underlying bladder cancer is important for the discovery of novel therapeutic paradigms for these diseases. In current study, we found that micro‐RNA (miR)‐190b is highly expressed in bladder cancer tissues and cells. Overexpression of miR‐190b enhanced the proliferation, growth, migration and invasion capabilities, and angiogenesis of bladder cancer cells, whereas downregulation of miR‐190b reversed these effects. Target prediction and dual luciferase reporter assays identified NLR family CARD domain containing 3 (NLRC3) as a potential target of miR‐190b. Pathway analysis indicated that miR‐190b promotes bladder cancer progression via the Wnt/β‐catenin and mTOR signaling pathways. Taken together, our findings imply that miR‐190b acts as a critical regulator for bladder cancer development by repressing NLRC3 and partly through the Wnt/β‐catenin and mTOR pathways. Our study suggests that miR‐190b may be served as a potential therapeutic target for bladder cancer treatment.